McLaren Health Care Appoints Justin F. Klamerus, MD, MMM, as Chief Medical Officer | McLaren Healthcare News

McLaren Health Care, the tri-state, 14-hospital health care system and plan, has named Justin F. Klamerus, MD, MMM, as executive vice president and chief medical officer. Dr Klamerus has been President of Karmanos Cancer Hospital & Network, a subsidiary of McLaren Health Care, since January 2017.

An oncologist by training, Dr Klamerus assumes the position previously held by Dr Michael McKenna, the first CMO of McLaren Health Care, who died in May.

“Over what has already been an outstanding career, Dr. Klamerus has proven himself to be a compassionate physician and a capable and confident leader, who has already developed a relationship with many of our leading physicians in the system,” said said Phil Incarnati, President and CEO of McLaren Health Care. “Dr. McKenna’s accomplishments at McLaren have gone a long way and he leaves a well-deserved legacy. His loss was very difficult for all of us, but it’s nice to know that one of his most trusted mentees will succeed him and take over. “will build on his significant contributions to clinical quality improvement. Dr. Klamerus will be a welcome addition to our leadership team.”

As Chief Medical Officer, Dr. Klamerus will recommend, develop and oversee the implementation of medical care aimed at improving patient clinical outcomes while establishing a single standard of care across the McLaren system. His immediate goals are to continue to build on McLaren’s established success in service excellence, clinical quality and health equity, solidifying the system as the healthcare provider of choice. in the communities it serves.

After graduating from Olivet College, Dr. Klamerus earned his MD from Michigan State University College of Human Medicine. He completed his residency in internal medicine – earning the position of chief resident – ​​at The Ohio State University before continuing his studies with a fellowship in medical oncology at Johns Hopkins University. In addition, he also earned a master’s degree in medical management from Heinz College, Carnegie Mellon University and completed the Health Management Academy’s General Electric Fellowship Program for Chief Medical Officers of Health.

In 2020, he was appointed to the Public Health Advisory Commission by Michigan Governor Gretchen Whitmer.

Dr. Klamerus’ history with McLaren began in 2009 when, as a practicing oncologist, he served as Director of the Cancer Services Program at McLaren Northern Michigan in Petoskey before becoming President of the McLaren Cancer Institute. . In 2014, when McLaren acquired the Karmanos Cancer Institute, he took on the role of Executive Vice President and Chief Quality Officer at Karmanos before being named President of the organization.

While at Karmanos, Dr. Klamerus oversaw the expansion of the Karmanos Cancer Network, growing it to 16 community treatment centers in Michigan and Ohio and uniting them under one standard of care by developing the guidelines structure. clinics, care plans and performance standards. He also led all business development and oversaw critical commercial and clinical partnerships with community physicians, university professors, and higher medical education partners.

Comments are closed.